Viewing Study NCT01294202


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-03-03 @ 8:32 PM
Study NCT ID: NCT01294202
Status: COMPLETED
Last Update Posted: 2024-08-02
First Post: 2011-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
Sponsor: Astex Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module